Article info

other Versions

Download PDFPDF
Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea

Authors

  1. Correspondence to Dr Joo-Young Kim, Proton Therapy Center, National Cancer Center, Goyang-si 10408, the Republic of Korea; jooyoungcasa{at}ncc.re.kr
View Full Text

Citation

Youn SH, Kim Y, Seo S, et al
Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea

Publication history

  • Received January 8, 2020
  • Revision received February 20, 2020
  • Accepted February 25, 2020
  • First published April 9, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.